ESWB Stock Chart & Stats
€24.70
-€0.57(-2.26%)
At close: 4:00 PM EDT
€24.70
-€0.57(-2.26%)
Day’s Range― - ―
52-Week Range€21.35 - €27.21
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€17.12B
Enterprise Value€222.70K
Total Cash (Recent Filing)€6.87B
Total Debt (Recent Filing)€42.61B
Price to Earnings (P/E)15.6
Beta0.28
Next Earnings
Oct 22, 2026EPS Estimate
0.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)17.72
Shares Outstanding625,831,900
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)2.13
Price to Sales (P/S)1.32
P/FCF Ratio21.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€23.60Price Target Upside-4.47% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering3
EPS Forecast (FY)1.72
Revenue Forecast (FY)€12.77B
Bulls Say, Bears Say
Bulls Say
Recurring Consumables ModelEssity's core business sells repeat consumables (incontinence, tissue, medical supplies) across retail, healthcare and away‑from‑home channels. High-frequency, usage‑driven demand and dispenser/refill systems create predictable recurring revenue and durable unit volumes, supporting stable cash flows and customer stickiness over multiple quarters.
Improved Profitability & DeleveragingProfitability has meaningfully strengthened versus 2022–23 while leverage has fallen materially. Higher operating and net margins, healthy mid‑teens ROE and lower debt ratios (net debt/EBITDA ~1.1 cited) increase financial resilience, allow reinvestment or buybacks, and reduce solvency risk during cyclical input cost swings.
Cost-savings Program & InnovationManagement is delivering operational savings while advancing product and digital initiatives (AI in engineering, Tork Vision). Realized COGS/SG&A savings and a >SEK1bn run‑rate target improve margin durability, and innovation/AI can lower development and procurement costs and speed new product rollouts, strengthening competitive positioning.
Bears Say
Volatile Revenue & Cash FlowHistorical swings in revenues and uneven free cash flow reduce predictability of operating performance and capital allocation. Choppy FCF (declines in 2024–25 before a TTM rebound) can constrain consistent investment, dividends or M&A, and increases funding and planning risk if volatility persists across business cycles.
Input Cost Inflation & Delayed Pass‑throughRising pulp, superabsorbers, wovens and energy materially raise COGS. Because price realization lags (1–2 quarters in consumer tissue, longer in regulated healthcare/contracts), margins face prolonged compression. This structural exposure to commodity and energy cycles can erode profitability despite cost programs.
Acquisition Integration DragIntegration of the North American acquisition has produced higher-than-expected costs and contractual service obligations that depress margins. Persistent acquisition-related drag raises execution risk for growth-through-M&A, delaying synergies and potentially weighing profitability for several quarters as contracts and operations are realigned.
Essity AB News
ESWB FAQ
What was Essity AB’s price range in the past 12 months?
Essity AB lowest stock price was €21.35 and its highest was €27.21 in the past 12 months.
What is Essity AB’s market cap?
Essity AB’s market cap is €17.12B.
When is Essity AB’s upcoming earnings report date?
Essity AB’s upcoming earnings report date is Oct 22, 2026 which is in 80 days.
How were Essity AB’s earnings last quarter?
Essity AB released its earnings results on Jul 16, 2026. The company reported €0.356 earnings per share for the quarter, missing the consensus estimate of €0.392 by -€0.036.
Is Essity AB overvalued?
According to Wall Street analysts Essity AB’s price is currently Overvalued.
Does Essity AB pay dividends?
Essity AB does not currently pay dividends.
What is Essity AB’s EPS estimate?
Essity AB’s EPS estimate is 0.4.
How many shares outstanding does Essity AB have?
Essity AB has 625,831,900 shares outstanding.
What happened to Essity AB’s price movement after its last earnings report?
Essity AB reported an EPS of €0.356 in its last earnings report, missing expectations of €0.392. Following the earnings report the stock price went down -2.767%.
Which hedge fund is a major shareholder of Essity AB?
Currently, no hedge funds are holding shares in DE:ESWB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Essity AB
Essity AB (publ) is a global manufacturer and distributor of personal care and wellness goods, along with related services. Its portfolio encompasses medical and healthcare items such as incontinence management solutions, wound care treatments, compression wear, orthopedic supports, skincare formulations, and advanced digital health tools featuring sensor technology. The company organizes its business into several divisions: Personal Care, Consumer Tissue, Professional Hygiene, and various other operations. Essity also manufactures a wide array of consumer products, including absorbent items (pads, diapers, washable absorbent underwear, menstrual cups, incontinence products), personal care items (wet wipes, skincare, intimate soaps), and paper goods (toilet papers, household towels, handkerchiefs, facial tissues, napkins). For professional settings, its hygiene offerings include restroom essentials (toilet papers, paper hand towels, napkins), hand care (soaps, lotions, sanitizers), dispensing systems, and cleaning/wiping solutions. Furthermore, the firm delivers digital innovations, particularly Internet of Things (IoT) sensor technology designed for data-driven facility management, alongside associated service and maintenance. These solutions cater to a diverse clientele, including corporate offices, educational institutions, healthcare providers, industrial sites, food service establishments, hospitality venues, sports arenas, and various other public spaces. Its medical and healthcare product lines, sold under brand names such as TENA, Leukoplast, Cutimed, JOBST, Actimove, and Delta-Cast, reach consumers through a variety of channels, including pharmacies, specialized medical device retailers, hospitals, authorized distributors, care facilities, and online platforms. Consumer products, featuring brands like Libero, Libresse, Nosotras, Saba, TOM Organic, Lotus, Regio, Tempo, and Vinda, are available via retail outlets and e-commerce. Professional hygiene items, branded as TORK, are distributed through intermediaries and digital storefronts. Essity's market presence extends across Europe, North America, Latin America, Asia, and other international regions. Established in 1849, Essity AB (publ) maintains its headquarters in Stockholm, Sweden.
ESWB Company Deck
ESWB Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
Balanced/Neutral. The quarter showed clear operational strengths: volume-driven sales growth across multiple business areas (notably Personal Care, Health & Medical, and Professional Hygiene), progress on cost-savings (SEK 160m COGS savings, SEK 100m SG&A benefit) and strong cash and leverage metrics (SEK 2.8bn cash flow, net debt/EBITDA 1.1). At the same time, notable near-term headwinds persist: Consumer Tissue weakness, margin declines (gross profit margin down ~70bps), acquisition-related cost drag in Personal Care, and expected higher COGS in Q3 from rising pulp, oil-based inputs and energy. Management is implementing price increases and accelerating integration and cost programs to offset these pressures, but timing lags mean margin recovery is not immediate.View all DE:ESWB earnings summariesESWB Net sales Breakdown
54.31% Consumer Goods
26.83% Professional Hygiene
18.84% Health & Medical
0.02% Other

ESWB Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€23.60
▼(-4.47% Downside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month






